Toxicity and cost-effectiveness analysis of intensity modulated radiation therapy versus 3-dimensional conformal radiation therapy for postoperative treatment of gynecologic cancers

Gynecologic Oncology

Volumn 136, Issue 3, 2015, Pages 521-528

  Chen, L Andy ^a   Kim, Jaewhan ^a   Boucher, Kenneth ^a   Terakedis, Breanne ^a   Williams, Britney ^a   Nickman, Nancy A ^b   Gaffney, David K ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF UTAH   (United States)

Author keywords

Cost benefit analysis; Endometrial neoplasms; Health care economics; Radiotherapy, conformal; Radiotherapy, intensity modulated; Uterine cervical neoplasms

Indexed keywords

CARBOPLATIN; CISPLATIN; DOCETAXEL; PACLITAXEL;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CHRONIC TOXICITY; COST EFFECTIVENESS ANALYSIS; FEMALE; GYNECOLOGIC CANCER; HEALTH CARE COST; HUMAN; HYSTERECTOMY; INTENSITY MODULATED RADIATION THERAPY; MAJOR CLINICAL STUDY; OVERALL SURVIVAL; POSTOPERATIVE CARE; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; UNIVARIATE ANALYSIS; UTERINE CERVIX CANCER; VERY ELDERLY; ADJUVANT THERAPY; ADVERSE EFFECTS; COMPARATIVE STUDY; COMPUTER ASSISTED RADIOTHERAPY; COST BENEFIT ANALYSIS; DECISION SUPPORT SYSTEM; ECONOMICS; EVALUATION STUDY; FACTUAL DATABASE; HOSPITAL COST; MIDDLE AGED; MORTALITY; POSTOPERATIVE PERIOD; PROCEDURES; REGISTER; RETROSPECTIVE STUDY; STATISTICS AND NUMERICAL DATA; SURVIVAL; TREATMENT OUTCOME; UNITED STATES; UTERINE CERVICAL NEOPLASMS; UTERINE NEOPLASMS;

ADULT; AGED; AGED, 80 AND OVER; COST-BENEFIT ANALYSIS; DATABASES, FACTUAL; DECISION SUPPORT TECHNIQUES; FEMALE; HOSPITAL COSTS; HUMANS; HYSTERECTOMY; MIDDLE AGED; POSTOPERATIVE PERIOD; QUALITY-ADJUSTED LIFE YEARS; RADIOTHERAPY, ADJUVANT; RADIOTHERAPY, CONFORMAL; RADIOTHERAPY, INTENSITY-MODULATED; REGISTRIES; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME; UTAH; UTERINE CERVICAL NEOPLASMS; UTERINE NEOPLASMS;

EID: 84924255900     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2014.12.039     Document Type: Article

References (30)

1. R.A. Nout, V.T. Smit, H. Putter, I.M. Jurgenliemk-Schulz, J.J. Jobsen, and L.C. Lutgens Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial Lancet 375 9717 2010 816 823
2. W.A. Peters 3rd, P.Y. Liu, R.J. Barrett 2nd, R.J. Stock, B.J. Monk, and J.S. Berek Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix J Clin Oncol 18 8 2000 1606 1613
3. C.L. Creutzberg, W.L. van Putten, P.C. Koper, M.L. Lybeert, J.J. Jobsen, and C.C. Warlam-Rodenhuis The morbidity of treatment for patients with Stage I endometrial cancer: results from a randomized trial Int J Radiat Oncol Biol Phys 51 5 2001 1246 1255
4. A.J. Mundt, A.E. Lujan, J. Rotmensch, S.E. Waggoner, S.D. Yamada, and G. Fleming Intensity-modulated whole pelvic radiotherapy in women with gynecologic malignancies Int J Radiat Oncol Biol Phys 52 5 2002 1330 1337
5. A.J. Mundt, L.K. Mell, and J.C. Roeske Preliminary analysis of chronic gastrointestinal toxicity in gynecology patients treated with intensity-modulated whole pelvic radiation therapy Int J Radiat Oncol Biol Phys 56 5 2003 1354 1360
6. A. Taylor, and M.E. Powell Conformal and intensity-modulated radiotherapy for cervical cancer Clin Oncol (R Coll Radiol) 20 6 2008 417 425
7. L.K. Mell, J.C. Roeske, and A.J. Mundt A survey of intensity-modulated radiation therapy use in the United States Cancer 98 1 2003 204 211
8. L.K. Mell, A.K. Mehrotra, and A.J. Mundt Intensity-modulated radiation therapy use in the U.S., 2004 Cancer 104 6 2005 1296 1303
9. J.D. Wright, I. Deutsch, E.T. Wilde, C.V. Ananth, A.I. Neugut, and S.N. Lewin Uptake and outcomes of intensity-modulated radiation therapy for uterine cancer Gynecol Oncol 130 1 2013 43 48
10. A. Jhingran, K. Winter, L. Portelance, B. Miller, M. Salehpour, and R. Gaur A phase II study of intensity modulated radiation therapy to the pelvis for postoperative patients with endometrial carcinoma: radiation therapy oncology group trial 0418 Int J Radiat Oncol Biol Phys 84 1 2012 e23 e28
11. W. Small Jr., L.K. Mell, P. Anderson, C. Creutzberg, Santos J. De Los, and D. Gaffney Consensus guidelines for delineation of clinical target volume for intensity-modulated pelvic radiotherapy in postoperative treatment of endometrial and cervical cancer Int J Radiat Oncol Biol Phys 71 2 2008 428 434
12. Healthcare Cost and Utilization Project (HCUP) National Inpatient Sample (NIS) [Internet] 2010
13. P. Reynisson, and J. Persson Hospital costs for robot-assisted laparoscopic radical hysterectomy and pelvic lymphadenectomy Gynecol Oncol 130 1 2013 95 99
14. N.T. Phippen, C.A. Leath 3rd, J.P. Chino, E.L. Jewell, L.J. Havrilesky, and J.C. Barnett Cost effectiveness of concurrent gemcitabine and cisplatin with radiation followed by adjuvant gemcitabine and cisplatin in patients with stages IIB to IVA carcinoma of the cervix Gynecol Oncol 127 2 2012 267 272
15. J.L. Lesnock, C. Farris, T.C. Krivak, K.J. Smith, and M. Markman Consolidation paclitaxel is more cost-effective than bevacizumab following upfront treatment of advanced epithelial ovarian cancer Gynecol Oncol 122 3 2011 473 478
16. E.L. Jewell, M. Smrtka, G. Broadwater, F. Valea, D.M. Davis, and K.C. Nolte Utility scores and treatment preferences for clinical early-stage cervical cancer Value Health 14 4 2011 582 586
17. J.A. Lachance, G.J. Stukenborg, B.F. Schneider, L.W. Rice, and A.A. Jazaeri A cost-effective analysis of adjuvant therapies for the treatment of stage I endometrial adenocarcinoma Gynecol Oncol 108 1 2008 77 83
18. M.H. Einstein, J.K. Rash, R.J. Chappell, J.M. Swietlik, J.P. Hollenberg, and J.P. Connor Quality of life in cervical cancer survivors: patient and provider perspectives on common complications of cervical cancer and treatment Gynecol Oncol 125 1 2012 163 167
19. R.J.G. Arnold Pharmacoeconomics: From Theory to Practice 2010 Taylor & Francis Boca Raton, FL [xiv, 243pp.]
20. W. Flanagan, C.N. McIntosh, C. Le Petit, and J.M. Berthelot Deriving utility scores for co-morbid conditions: a test of the multiplicative model for combining individual condition scores Popul Health Metrics 4 2006 13
21. R.W. Naumann, and R.L. Coleman The use of adjuvant radiation therapy in early endometrial cancer by members of the Society of Gynecologic Oncologists in 2005 Gynecol Oncol 105 1 2007 7 12
22. S. Beriwal, S.K. Jain, D.E. Heron, H. Kim, K. Gerszten, and R.P. Edwards Clinical outcome with adjuvant treatment of endometrial carcinoma using intensity-modulated radiation therapy Gynecol Oncol 102 2 2006 195 199
23. D.E. Heron, K. Gerszten, R.N. Selvaraj, G.C. King, D. Sonnik, and H. Gallion Conventional 3D conformal versus intensity-modulated radiotherapy for the adjuvant treatment of gynecologic malignancies: a comparative dosimetric study of dose-volume histograms small star, filled Gynecol Oncol 91 1 2003 39 45
24. R. Yang, S. Xu, W. Jiang, J. Wang, and C. Xie Dosimetric comparison of postoperative whole pelvic radiotherapy for endometrial cancer using three-dimensional conformal radiotherapy, intensity-modulated radiotherapy, and helical tomotherapy Acta Oncol 49 2 2010 230 236
25. M.R. Folkert, K.K. Shih, N.R. Abu-Rustum, E. Jewell, M.A. Kollmeier, and V. Makker Postoperative pelvic intensity-modulated radiotherapy and concurrent chemotherapy in intermediate- and high-risk cervical cancer Gynecol Oncol 128 2 2013 288 293
26. K.K. Shih, M.R. Folkert, M.A. Kollmeier, N.R. Abu-Rustum, Y. Sonoda, and M.M. Leitao Jr. Pelvic insufficiency fractures in patients with cervical and endometrial cancer treated with postoperative pelvic radiation Gynecol Oncol 128 3 2013 540 543
27. S. Chopra, T. Dora, A.N. Chinnachamy, B. Thomas, S. Kannan, and R. Engineer Predictors of grade 3 or higher late bowel toxicity in patients undergoing pelvic radiation for cervical cancer: results from a prospective study Int J Radiat Oncol Biol Phys 88 3 2014 630 635
28. K.K. Shih, S.A. Milgrom, N.R. Abu-Rustum, M.A. Kollmeier, G.J. Gardner, and W.P. Tew Postoperative pelvic intensity-modulated radiotherapy in high risk endometrial cancer Gynecol Oncol 128 3 2013 535 539
29. C. Marchal, M. Lapeyre, V. Beckendorf, P. Aletti, E. Hasle, and J.B. Dubois Preliminary results of the assessment of intensity modulated radiotherapy (IMRT) for prostatic and head and neck tumors (STIC 2001) Cancer Radiother 8 Suppl. 1 2004 S121 S127
30. J.L. Lesnock, C. Farris, S. Beriwal, and T.C. Krivak Upfront treatment of locally advanced cervical cancer with intensity modulated radiation therapy compared to four-field radiation therapy: a cost-effectiveness analysis Gynecol Oncol 129 3 2013 574 579